(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE UM AGONISTA INVERSO H3R PARA O TRATAMENTO DE SONOLÊNCIA DIURNA EXCESSIVA ASSOCIADA À DOENÇA DE PARKINSON (DP)

ArquivadaInvention PatentPCT · IB2019058651

Application data

Number

112021006366

Type

Invention Patent

Filing

10/10/2019

Publication

07/06/2021

PCT

IB2019058651

Progress at the INPI

  1. Filing10/10/19
  2. Publication07/06/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 10/10/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 04/04/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

NOVARTIS AG

CH

See this company's full portfolio

Inventors

D. J. (pessoa física)

US

J. S. (pessoa física)

CH

Technical data

Priority claims

US

62/744,153 · 10/11/2018

Abstract

USO DE UM AGONISTA INVERSO H3R PARA O TRATAMENTO DE SONOLÊNCIA DIURNA EXCESSIVA ASSOCIADA À DOENÇA DE PARKINSON (DP). A presente invenção refere-se ao uso do Composto (I), conforme definido no presente documento, ou sal farmaceuticamente aceitável do mesmo, no tratamento da sonolência diurna excessiva associada à doença de Parkinson.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

04/04/2023

RPI 2726

Arquivamento - Art. 33 da LPI

#11.1

01/17/2023

RPI 2715

Notificação de entrada na fase nacional - PCT

#1.3

07/06/2021

RPI 2635

Alteração de dados cadastrais

#1.1

04/13/2021

RPI 2623

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.